NCT00004381已完成2 期
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3 个研究点 分布在 1 个国家开始时间: 1999年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 3
研究概览
简要总结
OBJECTIVES: I. Compare the efficacy of preventive vs. therapeutic tin mesoporphyrin in direct Coombs' test-positive ABO hemolytic disease of the newborn and glucose-6-phosphate dehydrogenase deficiency in infants living in Greece.
II. Assess the safety of tin mesoporphyrin in high-risk newborns.
详细描述
PROTOCOL OUTLINE: Patients are stratified by gestational age and sex, and randomly assigned in pairs per stratum.
One group receives a preventive dose of tin mesoporphyrin. Another group receives a therapeutic dose of tin mesoporphyrin according to the plasma bilirubin concentration.
Patients in either group may be treated concurrently with phototherapy or exchange transfusion if clinically indicated.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 0 Years 至 24 Hours（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PROTOCOL ENTRY CRITERIA:
- •-Disease Characteristics-- Hyperbilirubinemia associated with either of the following: Direct Coombs' test-positive ABO hemolytic disease of the newborn Glucose-6-phosphate dehydrogenase deficiency --Prior/Concurrent Therapy-- No maternal phenobarbital in last month of pregnancy --Patient Characteristics-- Performance status: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: No congenital renal abnormality Cardiovascular: No congenital heart abnormality Pulmonary: No asphyxia requiring assisted ventilation at delivery Other: Gestational age more than 210 days Birth weight at least 1500 g No other major congenital abnormality, i.e.: Central nervous system Chromosomal Gastrointestinal No evident or suspected congenital infection, e.g.: Cytomegalovirus Herpes Rubella Syphilis
排除标准
- 未提供
研究者
研究点 (3)
Loading locations...
相似试验
已完成
1 期
Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of PorphyriaPorphyriaNCT00004397National Center for Research Resources (NCRR)20
已完成
2 期
Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature NewbornsHyperbilirubinemiaNCT00004382Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)80
已完成
1 期
Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of PorphyriaPorphyriaNCT00004398National Center for Research Resources (NCRR)24
已完成
2 期
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute PorphyriasPorphyriaNCT00004396National Center for Research Resources (NCRR)32
终止
2 期
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With CancerCancerVenous ThromboembolismNCT00981903University of Southern California131